Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01359839 · ClinicalTrials.gov registry record · NA

Effectiveness of a Relaxation-Response Based Cognitive Behavioral Therapy Group for Depressed Chinese Patients

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
40
Enrollment target

NCT01359839: Completed NA study, sponsored by Massachusetts General Hospital.

NCT01359839 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01359839, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The goal of this research is to evaluate whether group therapy combining Relaxation Response (RR) training and Cognitive Behavioral Therapy (CBT) in a group format merits further investigation in the treatment of Major Depressive Disorder (MDD). Specifically, the primary aim of this waitlist-controlled study is to gather preliminary data evaluating the effectiveness of RR-CBT group as treatment for patients with current MDD or a history of MDD, including patients who continue to be depressed despite taking antidepressants and patients who choose not to take antidepressants due to the fear of side effects and/or for personal reasons.

Interventions

  • BEHAVIORAL Relaxation Response and Cognitive Behavioral Therapy

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2010-08
Est. Completion 2011-12
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT01359839

The ClinicalTrials.gov registry entry for NCT01359839 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Relaxation Response and Cognitive Behavioral Therapy is the first listed.

NCT01359839 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01359839 about?

NCT01359839 is a clinical study titled "Effectiveness of a Relaxation-Response Based Cognitive Behavioral Therapy Group for Depressed Chinese Patients". The goal of this research is to evaluate whether group therapy combining Relaxation Response (RR) training and Cognitive Behavioral Therapy (CBT) in a group format merits further investigation in the treatment of Major Depressive Disorder (MDD). Specifically, the primary aim of this waitlist-control...

What is the current status of trial NCT01359839?

This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2010-08. Estimated completion is 2011-12.

What interventions are being tested in trial NCT01359839?

The interventions under investigation include: Relaxation Response and Cognitive Behavioral Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT01359839?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.